Agios Pharmaceuticals' Phase 3 ACTIVATE-KidsT study results reveal that mitapivat achieved a 28.1% transfusion reduction in children with PK deficiency compared to 11.8% with placebo. Secondary ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Agio Paper & Industries Ltd share price previously? Agio Paper & Industries Ltd share price was down by -4.99% ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...

View all information regarding the medicines that are manufactured by Agio Pharmaceuticals Ltd. including its generic drug name, trade name, how to use, the price, and its composition.